Iron
Iron contributes to normal formation of red blood cells and haemoglobin and plays an important role in normal oxygen transport.
Arovis Pharmaceuticals | Women’s Health / Nutritional Health
Arofera XT™
Ferrous Ascorbate + Folic Acid + Zinc Sulphate
AROVIS PHARMACEUTICALS
Ferrous Ascorbate + Folic Acid + Zinc Sulphate
Caring for life
Product overview
Arofera XT is focused on iron supplementation and nutritional support.
It combines iron, folic acid and zinc in a single formulation to support nutritional requirements where supplementation is indicated. It has particular relevance within the Arovis women’s-health portfolio, including periods such as pregnancy when nutritional requirements may increase.
Arofera XT combines iron, folic acid and zinc in a single formulation for nutritional supplementation where indicated.
Iron contributes to normal formation of red blood cells and haemoglobin, folate contributes to normal blood formation, and zinc contributes to normal metabolism and immune function.
Formulation science
Iron contributes to normal formation of red blood cells and haemoglobin and plays an important role in normal oxygen transport.
Folate contributes to normal blood formation and has an important role in cell division.
Zinc contributes to normal metabolism, immune function and protection of cells from oxidative stress.

Mechanism overview
An essential nutrient required for the formation of haemoglobin.
Supports normal oxygen transport through the body.
Supplementation may be recommended when dietary intake is insufficient or additional iron is clinically required.
Women’s Nutritional Needs Change With Life
Nutritional requirements can vary through different stages of life.
Iron and folate are important nutrients; supplementation should be professionally guided.
Individual supplementation after pregnancy should be determined by a healthcare professional.
Clinical positioning
Provides iron equivalent to 100 mg elemental iron per tablet according to the supplied formulation.
Provides 1.5 mg folic acid.
Provides zinc equivalent to 22.5 mg elemental zinc.
Supports responsible, physician-directed nutritional care.
Therapeutic focus
Use only under the direction of a qualified healthcare professional.

Quality and manufacturing
Arovis Pharmaceuticals follows a partner-based manufacturing model.
We work with selected third-party pharmaceutical manufacturing facilities that meet applicable regulatory and quality requirements.
Where applicable, relevant facilities may hold WHO-GMP certification within their approved scope and validity.
Responsible use
Iron requirements vary between individuals. Excessive iron intake may be harmful. The appropriate dose and duration should be determined by a qualified healthcare professional, particularly during pregnancy and in people with underlying medical conditions.
Responsible information
Arofera XT is a nutritional supplementation formulation containing Ferrous Ascorbate, Folic Acid and Zinc Sulphate.
According to the supplied product formulation, each tablet provides iron equivalent to 100 mg elemental iron, 1.5 mg folic acid and zinc equivalent to 22.5 mg elemental zinc.
Iron is required for normal haemoglobin formation and oxygen transport.
Iron and folate requirements can increase during pregnancy. Supplementation should be taken according to the advice of the treating healthcare professional.
Consult a healthcare professional before starting iron supplementation, particularly if you have an existing medical condition or take other medicines.
Arofera XT™
Iron + Folic Acid + Zinc
Restricted product information
Detailed formulation, therapeutic-focus and FAQ information is intended for qualified healthcare professionals or users accessing it under professional medical guidance.
This acknowledgement is not a substitute for legal review of pharmaceutical communication requirements.
Cookie preferences
AROVIS uses essential browser storage for site preferences. Analytics or marketing cookies will only be used when added and accepted.